Bangladesh not to prioritise Chinese COVID-19 Vaccine trial

▴ Bangladesh not to prioritise Chinese COVID-19 Vaccine trial
It remains a mystery why the Bangladesh government is still in a fix about allowing a clinical trial of the Chinese COVID-19 vaccine

It remains a mystery why the Bangladesh government is still in a fix about allowing a clinical trial of the Chinese COVID-19 vaccine here when health experts are saying the trial can help the country access the life-saving vaccine quickly and build national capacity for advanced research.

Globally, more than 100 organisations are working on COVID-19 vaccine development and governments are investing billions of dollars to get the vaccine at the soonest. The UK and US have also signed contracts with vaccine producers to this end.

Against this backdrop, it is an opportunity for Bangladesh to conduct a clinical trial of the vaccine here. The country should invite not only China but also other countries for vaccine research so it can be part of the global initiatives to fight the pandemic, say medical researchers.

Recently, Bangladesh Medical Research Council (BMRC), the regulator for medical research, has approved the trial of a vaccine developed by Chinese company -- Sinovac Research and Development Co Ltd -- for coronavirus treatment, after more than a month of review.

The company selected icddr,b, a globally reputed medical research organization, as its local partner in Bangladesh.

Making the decision public on July 19, BMRC Director Mahmood-uz-Jahan said icddr,b would now have to follow some procedures and get permissions from the Directorate General of Health Services (DGHS) and the Directorate General of Drug Administration (DGDA) for conducting the trial.

He also said the trial would be conducted on around 4,200 healthcare staffers.

But two days later, a private TV channel, quoting Health Secretary Abdul Mannan, reported that the approval for the trial was overturned.

Mannan did not clarify anything but said it was a matter of two states and the government would make a decision.

Health Minister Zahid Maleque, however, on July 22 said the government would decide on the trial of the Chinese vaccine upon consultation with the National Technical Advisory Committee (NTAC) on COVID-19. Contacted, NTAC Chair Prof Mohammad Shahidullah on July 28 told The Daily Star that the government had not yet sought any advice from the committee. "You please let us know if there is any decision," he said.

The Daily Star talked to four medical scientists having knowledge of vaccine development, but none of them wanted to speak on the record, saying that it has become a "geopolitical issue", which, they said, should not determine anything about the life-saving vaccine.


According to epidemiologists and virologists, three countries – the UK, US and China -- are now at the advanced stage of vaccine trials. The Oxford University of the UK and American biotechnology company Moderna have already begun their third phase trials in Brazil.

AstraZeneca, a partner of Oxford, also partnered with the Indian private vaccine maker Serum Institute of India to produce doses.

Of two Chinese companies, state-owned Sinopharma began stage-three trials in the UAE on 15,000 people, while Chinese private company Sinovac Research and Development Co Ltd signed a deal with a Brazilian organization for the phase-three trial. The BMRC of Bangladesh also approved the third phase trial of the Sinovac vaccine in Bangladesh.

Medical scientists say a global race is underway to develop an effective vaccine and ensure national demand before supplying doses to other nations. Any country participating in the trial will obviously get quick access to the vaccine, they said.

Sory Courtesy: 

Tags : #Bangladesh #ChineseCovidVaccine #ZahidMaleque #Sinovac #BMRC #BangladeshCovidNewsAug5

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

PM addresses the Nation today, announces free vaccinesJune 07, 2021
Why inhalers are best for treating asthma, well illustrated by Dr. Anil SingalMay 12, 2021
Dr. Rohan Palshetkar shares his invaluable insights about the Maternal Mortality Rate causes and improvements in India April 29, 2021
It is important to adopt a non-judgmental attitude towards any teenage girl seeking contraceptive advise suggests Dr. Teena Trivedi, Obstetrician and GynecologistApril 16, 2021
80% of the diseases are psychosomatic which means they have roots in the mind and this is where homeopathy steps in - It resolves physical ailments by finding the cause in the mind – Dr. Sanket Dhuri, Consultant Homeopath April 14, 2021
A futuristic Vision of a Healthcare Entrepreneur: Shyatto Raha, CEO, and Founder of MyHealthcareApril 12, 2021
Saher Mehdi, Founder and Chief Scientist at wellOwise talks about aspects making healthcare more equitable and reachableApril 10, 2021
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 09, 2021
Allopathic and Homeopathic medicines should not be taken together says Dr. Sunil Mehra, Homeopath ConsultantApril 08, 2021
The charm of homeopathic medicine is that it can be taken with conventional medicines – Dr. Shruthi Shridhar, Consulting Homeopath April 08, 2021
Dissociative Identity Disorder and associated concepts explained by Dr. Vinod Kumar, Psychiatrist and Head of Mpower - The Centre (Bangalore) April 07, 2021
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 05, 2021
Sehat Ki Baat, Karishma Ke Saath- Episode 6 Healthy Diet For Boosting Metabolism Which Can Help Thyroid Patients April 03, 2021
Significant Pointers on Kidney Health by Dr. Santosh Waigankar, Consultant Urooncologist and Robotic Surgeon at Kokilaben Dhirubhai Ambani HospitalApril 01, 2021
Dr. Vaishal Kenia, Ophthalmologist Talks About the Different Possibilities Available for the Treatment of Glaucoma Depending Upon Their Type and SeverityMarch 30, 2021
No Definitive Role of Diet in Treatment of Lymphedema but Intake of Calories, Salt and Long Chain Fatty Acids should be controlled says Dr. Ramani CVMarch 30, 2021
Dr. Kiran Chandra Patro, Senior Nephrologist Talks About Dialysis as the Temporary Process and Not a Permanent Cure for the Patients of Renal DysfunctionMarch 30, 2021
Two out of three new chronic kidney disease patients are found to have diabetes or hypertension informs Dr. Sreeharsha HarinathaMarch 30, 2021
Glaucoma Treatment: Medications or Surgery? A valuable piece of advice from Dr. Pranay Kapdia, Chairman and Medical Director of Kapadia Eye CareMarch 25, 2021
Dr. Shraddha Satav, Consultant Ophthalmologist Recommends that Everybody After 40, Should Go for the Complete Eye Checkup at Regular IntervalMarch 25, 2021